ModivCare Inc. (MODVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0150
+0.0050 (50.00%)
At close: Dec 29, 2025
ModivCare Revenue
ModivCare had revenue of $679.71M in the quarter ending September 30, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to $2.69B, down -3.40% year-over-year. In the year 2024, ModivCare had annual revenue of $2.79B with 1.32% growth.
Revenue (ttm)
2.69B
Revenue Growth
-3.40%
P/S Ratio
n/a
Revenue / Employee
113.74K
Employees
23,675
Market Cap
n/a
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.79B | 36.42M | 1.32% |
| Dec 31, 2023 | 2.75B | 246.78M | 9.85% |
| Dec 31, 2022 | 2.50B | 507.50M | 25.41% |
| Dec 31, 2021 | 2.00B | 628.22M | 45.90% |
| Dec 31, 2020 | 1.37B | -141.27M | -9.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
ModivCare News
- 18 days ago - Modivcare Successfully Completes Financial Restructuring, Reducing Debt by More Than 85% - Business Wire
- 5 weeks ago - Modivcare Announces Confirmation of Restructuring Plan - Business Wire
- 5 months ago - Modivcare Receives Nasdaq Delisting Notice Following Chapter 11 Filing - Business Wire
- 5 months ago - Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital - Business Wire
- 6 months ago - MODIVCARE ALERT: Bragar Eagel & Squire, P.C. Continues Investigating ModivCare, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - GlobeNewsWire
- 6 months ago - Modivcare Regains Compliance with Nasdaq Continued Listing Standard - Business Wire
- 7 months ago - Modivcare Celebrates Over a Decade of Serving Suffolk Community Member - Business Wire
- 7 months ago - ModivCare, Inc. (MODV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire